spacer
spacer

PDBsum entry 2f83

Go to PDB code: 
protein ligands metals links
Hydrolase PDB id
2f83

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
583 a.a. *
Ligands
NAG-NAG
NAG ×2
Metals
_PT ×2
Waters ×53
* Residue conservation analysis
PDB id:
2f83
Name: Hydrolase
Title: Crystal structure at 2.9 angstroms resolution of human plasma coagulation factor xi zymogen
Structure: Coagulation factor xi. Chain: a. Synonym: plasma thromboplastin antecedent, pta, fxi. Ec: 3.4.21.27
Source: Homo sapiens. Human. Organism_taxid: 9606
Resolution:
2.87Å     R-factor:   0.235     R-free:   0.281
Authors: E.Papagrigoriou,P.A.Mcewan,P.N.Walsh,J.Emsley
Key ref:
E.Papagrigoriou et al. (2006). Crystal structure of the factor XI zymogen reveals a pathway for transactivation. Nat Struct Mol Biol, 13, 557-558. PubMed id: 16699514 DOI: 10.1038/nsmb1095
Date:
01-Dec-05     Release date:   16-May-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P03951  (FA11_HUMAN) -  Coagulation factor XI from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
625 a.a.
583 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 

 
DOI no: 10.1038/nsmb1095 Nat Struct Mol Biol 13:557-558 (2006)
PubMed id: 16699514  
 
 
Crystal structure of the factor XI zymogen reveals a pathway for transactivation.
E.Papagrigoriou, P.A.McEwan, P.N.Walsh, J.Emsley.
 
  ABSTRACT  
 
Factor XI (FXI), a coagulation protein essential to normal hemostasis, circulates as a disulfide-linked dimer. Here we report the full-length FXI zymogen crystal structure, revealing that the protease and four apple domains assemble into a unique 'cup and saucer' architecture. The structure shows that the thrombin and platelet glycoprotein Ib binding sites are remote within the monomer but lie in close proximity across the dimer, suggesting a transactivation mechanism.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. FXI structure. (a) Topology of the four apple domains is represented with the protease domain removed. Connecting loops are colored black and the loop after A4, which leads to the C-terminal protease domain, is colored dark blue. (b) Topology of the FXI dimer with the protease domain colored red and Cys321 disulfide located centrally. (c) Two close-up views of the A4 dimer interface related by a 90° rotation. Left, interacting side chains from one side of the dimer interface are colored yellow, making contact with a charge-surface representation of the other half of the interface (blue, positive; red, negative). Right, a ribbon diagram shows a rotated view of the A4 dimer with hydrogen bonds and electrostatic interactions colored orange.
Figure 2.
Figure 2. FXI activation. (a) Ribbon diagrams representing zymogen activation by superposition of the FXIa structure (green; PDB entry 1ZJD) and the zymogen protease domain (yellow). The region of largest conformation change is the activation loop comprising residues 376–370. Ile370 side chain is colored purple in both structures. Active site Ser557 side chain is also shown. (b) Space-filling representation of the FXI dimer. White side chains, Arg369 and Ile370 from the activation loop; blue side chain, Lys252 and Lys253; red side chain, Glu66.
 
  The above figures are reprinted by permission from Macmillan Publishers Ltd: Nat Struct Mol Biol (2006, 13, 557-558) copyright 2006.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20432072 B.Woodruff, B.Sullenger, and R.C.Becker (2010).
Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?
  Curr Cardiol Rep, 12, 315-320.  
20724549 D.Gailani, M.F.Sun, Q.Cheng, A.Matafonov, E.I.Tucker, A.Gruber, and J.Emsley (2010).
Evidence against a protein in plasma that is a product of a factor XI mRNA splice variant missing exons 6 and 7.
  Blood, 116, 1185.  
20110423 J.Emsley, P.A.McEwan, and D.Gailani (2010).
Structure and function of factor XI.
  Blood, 115, 2569-2577.  
20042724 R.Asselta, V.Rimoldi, I.Guella, G.Soldà, R.De Cristofaro, F.Peyvandi, and S.Duga (2010).
Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA.
  Blood, 115, 2065-2072.  
19630773 D.Gailani, and S.B.Smith (2009).
Structural and functional features of factor XI.
  J Thromb Haemost, 7, 75-78.  
18186617 A.E.Schmidt, M.F.Sun, T.Ogawa, S.P.Bajaj, and D.Gailani (2008).
Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and beta-branching on the catalytic activity of blood coagulation factor XIa.
  Biochemistry, 47, 1326-1335.  
18388506 E.de Raucourt, P.de Mazancourt, and F.Quélin (2008).
Four novel FXI gene mutations in three factor XI- deficient patients.
  Blood Coagul Fibrinolysis, 19, 240-242.  
18761718 M.B.Ponczek, D.Gailani, and R.F.Doolittle (2008).
Evolution of the contact phase of vertebrate blood coagulation.
  J Thromb Haemost, 6, 1876-1883.  
19714257 S.B.Smith, and D.Gailani (2008).
Update on the physiology and pathology of factor IX activation by factor XIa.
  Expert Rev Hematol, 1, 87-98.  
18441012 W.Wu, D.Sinha, S.Shikov, C.K.Yip, T.Walz, P.C.Billings, J.D.Lear, and P.N.Walsh (2008).
Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.
  J Biol Chem, 283, 18655-18664.  
17971173 C.Bozzao, V.Rimoldi, R.Asselta, M.Landau, R.Ghiotto, M.L.Tenchini, R.De Cristofaro, G.Castaman, and S.Duga (2007).
A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency.
  FEBS J, 274, 6128-6138.  
17884987 D.Samuel, H.Cheng, P.W.Riley, A.A.Canutescu, C.Nagaswami, J.W.Weisel, Z.Bu, P.N.Walsh, and H.Roder (2007).
Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation.
  Proc Natl Acad Sci U S A, 104, 15693-15698.
PDB codes: 2j8j 2j8l
17922805 E.Hooley, P.A.McEwan, and J.Emsley (2007).
Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation.
  J Thromb Haemost, 5, 2461-2466.  
17890078 I.Botos, and A.Wlodawer (2007).
The expanding diversity of serine hydrolases.
  Curr Opin Struct Biol, 17, 683-690.  
17418146 P.Brennwald, and G.Rossi (2007).
Spatial regulation of exocytosis and cell polarity: yeast as a model for animal cells.
  FEBS Lett, 581, 2119-2124.  
17257616 P.W.Riley, H.Cheng, D.Samuel, H.Roder, and P.N.Walsh (2007).
Dimer dissociation and unfolding mechanism of coagulation factor XI apple 4 domain: spectroscopic and mutational analysis.
  J Mol Biol, 367, 558-573.  
18020374 T.N.Miller, D.Sinha, T.R.Baird, and P.N.Walsh (2007).
A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets.
  Biochemistry, 46, 14450-14460.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer